Leading the team aiming to bring to market the solution to end the chronic wound epidemic. This devastating condition affects the elderly and those who suffer from comorbidities such as diabetes and vascular disease. Many patients with chronic wounds not only bear the physical pain of their medical condition, but also are often isolated and sequestered to their beds due to off-loading protocols. Their lives are severely disrupted and patients often spend hundreds of dollars a month out of their own pocket to cover materials needed to care for their wounds. The psychological pain and fear of amputation are the silent companions of their suffering.
The statistics point to injustices as African-American patients receive amputations at twice the rate of their white counterparts. For patients with vascular disease and chronic wounds, their 5-year mortality rate rivals the five-year mortality rates of cancer patients. Yet, because chronic wounds are not a branded disease and receive little fan fair, few research dollars flow to solve this crisis that is at epidemic levels.
Previously a founding member of Pearl Capital Advisors LLC—an award-winning investment management firm specializing in volatility-based investments where, as CIO, I led investment research, risk management, and marketing efforts for Pearl’s investment strategies.
Leading the team aiming to bring to market the solution to end the chronic wound epidemic. This devastating condition affects the elderly and those who suffer from comorbidities such as diabetes and vascular disease. Many patients with chronic wounds not only bear the physical pain of their medical condition, but also are often isolated and sequestered to their beds due to off-loading protocols. Their lives are severely disrupted and patients often spend hundreds of dollars a month out of their own pocket to cover materials needed to care for their wounds. The psychological pain and fear of amputation are the silent companions of their suffering.
The statistics point to injustices as African-American patients receive amputations at twice the rate of their white counterparts. For patients with vascular disease and chronic wounds, their 5-year mortality rate rivals the five-year mortality rates of cancer patients. Yet, because chronic wounds are not a branded disease and receive little fan fair, few research dollars flow to solve this crisis that is at epidemic levels.
Previously a founding member of Pearl Capital Advisors LLC—an award-winning investment management firm specializing in volatility-based investments where, as CIO, I led investment research, risk management, and marketing efforts for Pearl’s investment strategies.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy